Imjudo Euroopa Liit - islandi - EMA (European Medicines Agency)

imjudo

astrazeneca ab - tremelimumab - carcinoma, hepatocellular - Æxlishemjandi lyf - imjudo in combination with durvalumab is indicated for the first line treatment of adults with advanced or unresectable hepatocellular carcinoma (hcc). imjudo in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

Pulmicort Dreifa í eimgjafa 0,125 mg/ml Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,125 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,125 mg/ml

Pulmicort Dreifa í eimgjafa 0,25 mg/ml Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,25 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,25 mg/ml

Pulmicort Dreifa í eimgjafa 0,5 mg/ml Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort dreifa í eimgjafa 0,5 mg/ml

astrazeneca a/s - budesonidum inn - dreifa í eimgjafa - 0,5 mg/ml

Pulmicort Turbuhaler Innöndunarduft 100 míkróg/skammt Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort turbuhaler innöndunarduft 100 míkróg/skammt

astrazeneca a/s - budesonidum inn - innöndunarduft - 100 míkróg/skammt

Pulmicort Turbuhaler Innöndunarduft 200 míkróg/skammt Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort turbuhaler innöndunarduft 200 míkróg/skammt

astrazeneca a/s - budesonidum inn - innöndunarduft - 200 míkróg/skammt

Pulmicort Turbuhaler Innöndunarduft 400 míkróg/skammt Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

pulmicort turbuhaler innöndunarduft 400 míkróg/skammt

astrazeneca a/s - budesonidum inn - innöndunarduft - 400 míkróg/skammt

Bricanyl Turbuhaler Innöndunarduft 0,5 mg/úðaskammt Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

bricanyl turbuhaler innöndunarduft 0,5 mg/úðaskammt

astrazeneca a/s - terbutalinum súlfat - innöndunarduft - 0,5 mg/úðaskammt

Bricanyl Turbuhaler Innöndunarduft 0,25 mg/úðaskammt Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

bricanyl turbuhaler innöndunarduft 0,25 mg/úðaskammt

astrazeneca a/s - terbutalinum súlfat - innöndunarduft - 0,25 mg/úðaskammt

Oxis Turbuhaler Innöndunarduft 4,5 míkrog/skammt Island - islandi - LYFJASTOFNUN (Icelandic Medicines Agency)

oxis turbuhaler innöndunarduft 4,5 míkrog/skammt

astrazeneca a/s - formoterolum fúmarat - innöndunarduft - 4,5 míkrog/skammt